Document is current
Any future updates will be listed below
-
Authors
Rzechorzek, Neil J. https://orcid.org/0000-0003-2068-1424
Kunzelmann, Simone https://orcid.org/0000-0002-2678-0549
Purkiss, Andrew G. https://orcid.org/0000-0002-5931-3509
Silva Dos Santos, Mariana https://orcid.org/0000-0003-2404-8490
MacRae, James I. https://orcid.org/0000-0002-1464-8583
Taylor, Ian A. https://orcid.org/0000-0002-6763-3852
Fugger, Kasper
West, Stephen C. https://orcid.org/0000-0001-8848-9418
- License Information
-
More Information
Article History
Received: 23 August 2023
Accepted: 13 October 2023
First Online: 26 October 2023
Competing interests
: K.F. and S.C.W. are inventors on patent WO2021/048235 that pertains to the use of DNPH1 inhibitors and hmdU as a mechanism to sensitise HR-deficient cells to PARPi. The remaining authors declare no competing interests.
